Trial Outcomes & Findings for Correction of Myopia Evaluation Trial 2 (NCT NCT00320593)

NCT ID: NCT00320593

Last Updated: 2016-07-19

Results Overview

Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is the sphere plus 1/2 the cylinder. For baseline and each time point, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

118 participants

Primary outcome timeframe

Baseline to 3 years

Results posted on

2016-07-19

Participant Flow

Between April 2005 and March 2007, 118 subjects age 8 to \<12 years were enrolled in the study at 8 clinical centers.

Participant milestones

Participant milestones
Measure
Progressive Addition Lenses (PALs)
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
Standard single vision lenses
Overall Study
STARTED
59
59
Overall Study
COMPLETED
52
58
Overall Study
NOT COMPLETED
7
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Progressive Addition Lenses (PALs)
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
Standard single vision lenses
Overall Study
Lost to Follow-up
3
0
Overall Study
Moved to another state
1
0
Overall Study
Withdrawal by Subject
2
1
Overall Study
Withdrawal by clinical center
1
0

Baseline Characteristics

Correction of Myopia Evaluation Trial 2

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Progressive Addition Lenses (PALs)
n=59 Participants
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
n=59 Participants
Standard single vision lenses
Total
n=118 Participants
Total of all reporting groups
Age, Continuous
10.2 years
STANDARD_DEVIATION 1.1 • n=5 Participants
10.0 years
STANDARD_DEVIATION 1.1 • n=7 Participants
10.1 years
STANDARD_DEVIATION 1.1 • n=5 Participants
Age, Customized
8 to <9 years
8 participants
n=5 Participants
14 participants
n=7 Participants
22 participants
n=5 Participants
Age, Customized
9 to <10 years
15 participants
n=5 Participants
17 participants
n=7 Participants
32 participants
n=5 Participants
Age, Customized
10 to <11 years
18 participants
n=5 Participants
14 participants
n=7 Participants
32 participants
n=5 Participants
Age, Customized
11 to <12 years
18 participants
n=5 Participants
14 participants
n=7 Participants
32 participants
n=5 Participants
Sex: Female, Male
Female
36 Participants
n=5 Participants
28 Participants
n=7 Participants
64 Participants
n=5 Participants
Sex: Female, Male
Male
23 Participants
n=5 Participants
31 Participants
n=7 Participants
54 Participants
n=5 Participants
Race/Ethnicity, Customized
White
28 participants
n=5 Participants
31 participants
n=7 Participants
59 participants
n=5 Participants
Race/Ethnicity, Customized
African American
14 participants
n=5 Participants
10 participants
n=7 Participants
24 participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic or Latino
10 participants
n=5 Participants
12 participants
n=7 Participants
22 participants
n=5 Participants
Race/Ethnicity, Customized
Asian
5 participants
n=5 Participants
4 participants
n=7 Participants
9 participants
n=5 Participants
Race/Ethnicity, Customized
Other
2 participants
n=5 Participants
2 participants
n=7 Participants
4 participants
n=5 Participants
Region of Enrollment
United States
59 participants
n=5 Participants
59 participants
n=7 Participants
118 participants
n=5 Participants
Spectacle wear (single vision lenses)
Currently
33 participants
n=5 Participants
33 participants
n=7 Participants
66 participants
n=5 Participants
Spectacle wear (single vision lenses)
In past but not currently
4 participants
n=5 Participants
2 participants
n=7 Participants
6 participants
n=5 Participants
Spectacle wear (single vision lenses)
Never
22 participants
n=5 Participants
24 participants
n=7 Participants
46 participants
n=5 Participants
Average Spherical Equivalent Between the Eyes
-0.75 to -0.99 diopters (D)
8 participants
n=5 Participants
12 participants
n=7 Participants
20 participants
n=5 Participants
Average Spherical Equivalent Between the Eyes
-1.00 to -1.49 D
22 participants
n=5 Participants
23 participants
n=7 Participants
45 participants
n=5 Participants
Average Spherical Equivalent Between the Eyes
-1.50 to -1.99 D
18 participants
n=5 Participants
14 participants
n=7 Participants
32 participants
n=5 Participants
Average Spherical Equivalent Between the Eyes
-2.00 to -2.50 D
11 participants
n=5 Participants
10 participants
n=7 Participants
21 participants
n=5 Participants
Average Spherical Equivalent Between the Eyes
-1.50 diopters
STANDARD_DEVIATION 0.45 • n=5 Participants
-1.45 diopters
STANDARD_DEVIATION 0.47 • n=7 Participants
-1.48 diopters
STANDARD_DEVIATION 0.46 • n=5 Participants
Average J0 Between the Eyes
-0.02 diopters
STANDARD_DEVIATION 0.18 • n=5 Participants
-0.02 diopters
STANDARD_DEVIATION 0.15 • n=7 Participants
-0.02 diopters
STANDARD_DEVIATION 0.16 • n=5 Participants
Average J45 Between the Eyes
0.11 diopters
STANDARD_DEVIATION 0.07 • n=5 Participants
0.10 diopters
STANDARD_DEVIATION 0.07 • n=7 Participants
0.11 diopters
STANDARD_DEVIATION 0.07 • n=5 Participants
Anisometropia
0.22 diopters
STANDARD_DEVIATION 0.20 • n=5 Participants
0.21 diopters
STANDARD_DEVIATION 0.16 • n=7 Participants
0.22 diopters
STANDARD_DEVIATION 0.18 • n=5 Participants
Near Esophoria
2 to 5 prism diopters (PD)
33 participants
n=5 Participants
34 participants
n=7 Participants
67 participants
n=5 Participants
Near Esophoria
6 to 10 PD
22 participants
n=5 Participants
21 participants
n=7 Participants
43 participants
n=5 Participants
Near Esophoria
11 to 15 PD
3 participants
n=5 Participants
3 participants
n=7 Participants
6 participants
n=5 Participants
Near Esophoria
16 to 20 PD
1 participants
n=5 Participants
1 participants
n=7 Participants
2 participants
n=5 Participants
Near Esophoria
5.8 prism diopters
STANDARD_DEVIATION 3.2 • n=5 Participants
5.9 prism diopters
STANDARD_DEVIATION 3.4 • n=7 Participants
5.9 prism diopters
STANDARD_DEVIATION 3.3 • n=5 Participants
Accommodative Lag
0.50 to 0.99 diopters (D)
8 participants
n=5 Participants
6 participants
n=7 Participants
14 participants
n=5 Participants
Accommodative Lag
1.00 to 1.49 D
26 participants
n=5 Participants
33 participants
n=7 Participants
59 participants
n=5 Participants
Accommodative Lag
1.50 to 1.99 D
13 participants
n=5 Participants
16 participants
n=7 Participants
29 participants
n=5 Participants
Accommodative Lag
2.00 D or more
12 participants
n=5 Participants
4 participants
n=7 Participants
16 participants
n=5 Participants
Accommodative Lag
1.47 diopters
STANDARD_DEVIATION 0.53 • n=5 Participants
1.40 diopters
STANDARD_DEVIATION 0.48 • n=7 Participants
1.44 diopters
STANDARD_DEVIATION 0.50 • n=5 Participants
Parental History of Myopia
Neither parent
10 participants
n=5 Participants
5 participants
n=7 Participants
15 participants
n=5 Participants
Parental History of Myopia
One parent
16 participants
n=5 Participants
10 participants
n=7 Participants
26 participants
n=5 Participants
Parental History of Myopia
Both parents
18 participants
n=5 Participants
20 participants
n=7 Participants
38 participants
n=5 Participants
Parental History of Myopia
Missing/unknown
15 participants
n=5 Participants
24 participants
n=7 Participants
39 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline to 3 years

Population: The analysis followed the intent-to-treat principle.

Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is the sphere plus 1/2 the cylinder. For baseline and each time point, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.

Outcome measures

Outcome measures
Measure
Progressive Addition Lenses (PALs)
n=52 Participants
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
n=58 Participants
Standard single vision lenses
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
0.00 to -0.49 D
11 participants
8 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
-0.50 to -0.99 D
16 participants
13 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
-1.00 to -1.49 D
12 participants
13 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
<= -1.50 D (more myopia)
7 participants
21 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
>0.00 D (less myopia)
6 participants
3 participants

PRIMARY outcome

Timeframe: 3 years

Population: All analyses followed the intent-to-treat principle. The Monte Carlo Markov Chain (MCMC) method of multiple imputation was used to impute data for subjects who did not complete the 3-year visit.

Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and each time point, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.

Outcome measures

Outcome measures
Measure
Progressive Addition Lenses (PALs)
n=52 Participants
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
n=58 Participants
Standard single vision lenses
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years
-0.87 diopters
Standard Deviation 0.72
-1.15 diopters
Standard Deviation 0.75

SECONDARY outcome

Timeframe: 3 years

Population: The analysis followed the intent-to-treat principle.

Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. A SE was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the SE used for analysis.

Outcome measures

Outcome measures
Measure
Progressive Addition Lenses (PALs)
n=52 Participants
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
n=58 Participants
Standard single vision lenses
Distribution of Spherical Equivalent Refractive Error at 3 Years
-3.00 to -3.99 D
8 participants
17 participants
Distribution of Spherical Equivalent Refractive Error at 3 Years
-2.00 to -2.99 D
20 participants
21 participants
Distribution of Spherical Equivalent Refractive Error at 3 Years
Better than or equal to -0.49 D
0 participants
1 participants
Distribution of Spherical Equivalent Refractive Error at 3 Years
-0.50 to -0.99 D
2 participants
1 participants
Distribution of Spherical Equivalent Refractive Error at 3 Years
Worse than or equal to -4.00 D
4 participants
4 participants
Distribution of Spherical Equivalent Refractive Error at 3 Years
-1.00 to -1.99 D
18 participants
14 participants

SECONDARY outcome

Timeframe: 3 years

Population: The analysis followed the intent-to-treat principle.

Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. A SE was calculated for each eye for each of the five trials of cycloplegic autorefraction, and the median for each eye was averaged to obtain the SE used for analysis.

Outcome measures

Outcome measures
Measure
Progressive Addition Lenses (PALs)
n=52 Participants
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
n=58 Participants
Standard single vision lenses
Mean Spherical Equivalent Refractive Error at 3 Years
-2.41 diopters
Standard Deviation 0.95
-2.60 diopters
Standard Deviation 0.91

SECONDARY outcome

Timeframe: Baseline to 3 years

Population: The analysis followed the intent-to-treat principle.

Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 3 years, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.

Outcome measures

Outcome measures
Measure
Progressive Addition Lenses (PALs)
n=52 Participants
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
n=58 Participants
Standard single vision lenses
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Gender: Male
19 participants
31 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Gender: Female
33 participants
27 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Age at baseline: 8 to <9 years
8 participants
13 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Age at baseline: 9 to <10 years
13 participants
17 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Age at baseline: 10 to <11 years
15 participants
14 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Age at baseline: 11 to <12 years
16 participants
14 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Race/Ethnicity: White
26 participants
30 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Race/Ethnicity: Nonwhite
26 participants
28 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Prior spectacle wear: Currently or in past
31 participants
34 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Prior spectacle wear: Never
21 participants
24 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Spherical equivalent at baseline: -0.75 to -1.49 D
25 participants
33 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Spherical equivalent at baseline: -1.50 to -2.50 D
27 participants
25 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Accommodative lag at baseline: 0.50 to 1.49 D
28 participants
38 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Accommodative lag at baseline: 1.50 or worse
24 participants
20 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Near esophoria at baseline: 2 to 5 PD
30 participants
33 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Near esophoria at baseline: 6 to 10 PD
18 participants
21 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Near esophoria at baseline: >10 PD
4 participants
4 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Parental history of myopia: Neither parent
9 participants
5 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Parental history of myopia: One parent
15 participants
10 participants
Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Parental history of myopia: Both parents
18 participants
20 participants

SECONDARY outcome

Timeframe: Baseline to 3 years

Population: The analysis followed the intent-to-treat principle.

Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 3 years, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.

Outcome measures

Outcome measures
Measure
Progressive Addition Lenses (PALs)
n=52 Participants
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
n=58 Participants
Standard single vision lenses
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Age at baseline: 8 to <9 years
-1.23 diopters
Standard Deviation 1.06
-1.39 diopters
Standard Deviation 0.79
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Age at baseline: 9 to <10 years
-1.11 diopters
Standard Deviation 0.76
-1.14 diopters
Standard Deviation 0.78
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Age at baseline: 10 to <11 years
-0.71 diopters
Standard Deviation 0.52
-1.19 diopters
Standard Deviation 0.81
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Age at baseline: 11 to <12 years
-0.64 diopters
Standard Deviation 0.55
-0.88 diopters
Standard Deviation 0.58
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Gender: Male
-0.95 diopters
Standard Deviation 0.64
-1.09 diopters
Standard Deviation 0.75
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Gender: Female
-0.82 diopters
Standard Deviation 0.76
-1.21 diopters
Standard Deviation 0.76
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Race/Ethnicity: White
-0.79 diopters
Standard Deviation 0.74
-1.10 diopters
Standard Deviation 0.76
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Race/Ethnicity: Nonwhite
-0.94 diopters
Standard Deviation 0.70
-1.19 diopters
Standard Deviation 0.75
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Prior spectacle wear: Currently or in past
-0.90 diopters
Standard Deviation 0.75
-1.10 diopters
Standard Deviation 0.63
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Prior spectacle wear: Never
-0.81 diopters
Standard Deviation 0.68
-1.22 diopters
Standard Deviation 0.90
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Spherical equivalent at baseline: -0.75 to -1.49 D
-0.79 diopters
Standard Deviation 0.61
-1.20 diopters
Standard Deviation 0.76
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Spherical equivalent at baseline: -1.50 to -2.50 D
-0.93 diopters
Standard Deviation 0.81
-1.08 diopters
Standard Deviation 0.75
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Accommodative lag at baseline: 0.50 to 1.49 D
-0.91 diopters
Standard Deviation 0.59
-1.12 diopters
Standard Deviation 0.72
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Accommodative lag at baseline: 1.50 or worse
-0.81 diopters
Standard Deviation 0.86
-1.20 diopters
Standard Deviation 0.82
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Near esophoria at baseline: 2 to 5 PD
-0.97 diopters
Standard Deviation 0.82
-1.13 diopters
Standard Deviation 0.79
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Near esophoria at baseline: 6 to 10 PD
-0.66 diopters
Standard Deviation 0.54
-1.09 diopters
Standard Deviation 0.67
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Near esophoria at baseline: >10 PD
-1.01 diopters
Standard Deviation 0.43
-1.60 diopters
Standard Deviation 0.86
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Parental history of myopia: Neither parent
-0.83 diopters
Standard Deviation 0.63
-0.72 diopters
Standard Deviation 0.76
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Parental history of myopia: One parent
-0.73 diopters
Standard Deviation 0.52
-1.28 diopters
Standard Deviation 0.62
Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics
Parental history of myopia: Both parents
-0.99 diopters
Standard Deviation 0.79
-1.29 diopters
Standard Deviation 0.87

SECONDARY outcome

Timeframe: Baseline to 1 year

Population: The analysis followed the intent-to-treat principle.

Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 1 year, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 1 year. A negative value indicates that the myopia worsened; a positive value indicates that it improved.

Outcome measures

Outcome measures
Measure
Progressive Addition Lenses (PALs)
n=55 Participants
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
n=58 Participants
Standard single vision lenses
Mean Change in Spherical Equivalent Refractive Error From Baseline to 1 Year
-0.29 diopters
Standard Deviation 0.39
-0.42 diopters
Standard Deviation 0.37

SECONDARY outcome

Timeframe: Baseline to 2 years

Population: The analysis followed the intent-to-treat principle

Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and 2 years, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 2 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.

Outcome measures

Outcome measures
Measure
Progressive Addition Lenses (PALs)
n=55 Participants
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
n=58 Participants
Standard single vision lenses
Mean Change in Spherical Equivalent Refractive Error From Baseline to 2 Years
-0.58 diopters
Standard Deviation 0.55
-0.80 diopters
Standard Deviation 0.61

SECONDARY outcome

Timeframe: Baseline to 3 years

Population: The analysis followed the intent-to-treat principle. Two patients had no compliance data because they had no follow-up visits (one single vision lenses, and one progressive-addition lenses).

Spectacle compliance was assessed on a five-point Likert scale: always, 5; often, 4; sometimes, 3; rarely, 2; and never, 1. Excellent compliance indicates that for the specified period (during school, after school, on weekends), spectacles were estimated at all visits to have been worn either always or often.

Outcome measures

Outcome measures
Measure
Progressive Addition Lenses (PALs)
n=58 Participants
Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition
Single Vision Lenses (SVLs)
n=58 Participants
Standard single vision lenses
Excellent Spectacle Compliance
During school
72 percent of participants
90 percent of participants
Excellent Spectacle Compliance
After school
60 percent of participants
76 percent of participants
Excellent Spectacle Compliance
Weekends
60 percent of participants
71 percent of participants

Adverse Events

Progressive Addition Lenses (PALs)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Single Vision Lenses (SVLs)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Raymond Kraker, MSPH

Jaeb Center for Health Research

Phone: 813-875-8690

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place